My understanding is it's bleed vs. no bleed (at this stage). To localise/confirm a large vessel occlusion that is a target for endovascular clot retrieval (ECR), the standard today is a CT Stroke series - which consists of a non-contrast CT brain + CT angiogram (Aortic Arch to Circle of Willis) +/- CT perfusion. A CT Stroke series also needs IV contrast for the angiography phase.
I don't think the EMVision technology can be used to localise the site of a large vessel occlusion. But that isn't it's purpose, which is to exclude a haemorrhagic stroke (and presumably) allow for earlier administration of tPA.
My personal opinion is that its main use will be in the prehospital environment, mainly rurally - where time to CT is very long. In metropolitan emergency departments, the time to CT will be the same as time to emu, so there won't be much benefit in using the emu, when CT can be done (which will give you an angiogram to localise a large vessel occlusion if its present) as well as exclude a haemorrhagic stroke.
Another possible use for emu, could (potentially) be to rule out traumatic intracranial bleeds. E.g. old man on aspirin has an fall and a head strike. This universally gets a non-contrast CT brain. The emu scan would be a good option to triage high risk patients (e.g. high risk for a traumatic intracranial bleed)
- Forums
- ASX - By Stock
- EMV
- Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability, page-36
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMV (ASX) to my watchlist
|
|||||
Last
$2.15 |
Change
0.100(4.88%) |
Mkt cap ! $183.6M |
Open | High | Low | Value | Volume |
$2.05 | $2.15 | $2.05 | $33.01K | 15.72K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9000 | $2.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.15 | 3963 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9000 | 2.100 |
1 | 4000 | 2.080 |
2 | 524 | 2.050 |
1 | 32 | 2.010 |
1 | 5000 | 2.000 |
Price($) | Vol. | No. |
---|---|---|
2.150 | 3963 | 2 |
2.200 | 21000 | 1 |
2.220 | 1000 | 1 |
2.250 | 1250 | 1 |
2.380 | 300 | 1 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online